文献速递角膜与眼表疾病

磁性人角膜内皮细胞移植:递送、滞留与短期疗效

Magnetic Human Corneal Endothelial Cell Transplant: Delivery, Retention, and Short-Term Efficacy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

研究将表达绿色荧光蛋白并负载超顺磁性纳米颗粒的原代人角膜内皮细胞注入兔眼前房,比较不同角膜水肿模型;移植细胞在完整后弹力层上形成单层并表达紧密连接标志物,未在房角或虹膜检出,眼压稳定;磁性细胞递送可恢复角膜透明且未观察到毒性,作者认为应进一步探索用于人类治疗。

要点

  • 磁性人角膜内皮细胞可整合于完整后弹力层并形成单层。
  • 移植眼未在房角或虹膜检出绿色荧光蛋白阳性细胞,眼压稳定。
  • 作者认为磁性递送人角膜内皮细胞应进一步探索用于人类治疗。

核心结论

  • 磁性细胞疗法能高效递送人角膜内皮细胞以恢复角膜透明,未检测到毒性或对眼压的不良影响。
  • 作者认为磁性递送人角膜内皮细胞可能增强角膜功能,应进一步探索用于人类治疗。

研究设计与样本

  • 原代人角膜内皮细胞取自尸体供体角膜,体外扩增后转导表达绿色荧光蛋白并负载超顺磁性纳米颗粒,在内皮细胞或后弹力层剥离后立即注入成年兔眼前房。
  • 对照眼注射等体积平衡盐溶液加强型(BSS+)。
  • 比较不同兔角膜水肿诱导模型,并通过测量中央角膜厚度和追踪角膜透明度评估移植细胞随时间减轻角膜水肿的能力。
  • 用光学相干断层扫描(OCT)荧光血管成像模块在体内追踪绿色荧光蛋白阳性供体细胞,并通过人细胞核免疫染色确认移植细胞。

主要发现

  • 磁性人角膜内皮细胞整合到后弹力层完整的受体角膜上,供体身份经绿色荧光蛋白表达和人细胞核标志物免疫染色确认。
  • 供体人角膜内皮细胞在后角膜表面形成单层,并表达紧密连接形成的人角膜内皮细胞功能标志物。
  • 房角小梁网或虹膜上未观察到绿色荧光蛋白阳性细胞,研究全程眼压保持稳定。

临床怎么用

  • 原文结论未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Corneal endothelial dysfunction leads to corneal edema, pain, and vision loss. Adequate animal models are needed to study the safety and efficacy of novel cell therapies as an alternative to corneal transplantation. METHODS: Primary human corneal endothelial cells (HCECs) were isolated from cadaveric donor corneas, expanded in vitro, transduced to express green fluorescent protein (GFP), loaded with superparamagnetic nanoparticles, and injected into the anterior chamber of adult rabbits immediately after endothelial cell or Descemet's membrane stripping. The same volume of balanced salt solution plus (BSS+) was injected in control eyes. We compared different models for inducing corneal edema in rabbits, and examined the ability of transplanted HCECs to reduce corneal edema over time by measuring central corneal thickness and tracking corneal clarity. GFP-positive donor cells were tracked in vivo using optical coherence tomography (OCT) fluorescence angiography module, and the transplanted cells were confirmed by human nuclei immunostaining. RESULTS: Magnetic HCECs integrated onto the recipient corneas with intact Descemet's membrane, and donor identity was confirmed by GFP expression and immunostaining for human nuclei marker. Donor HCECs formed a monolayer on the posterior corneal surface and expressed HCEC functional markers of tight junction formation. No GFP-positive cells were observed in the trabecular meshwork or on the iris, and intraocular pressure remained stable through the length of the study. CONCLUSIONS: Our results demonstrate magnetic cell-based therapy efficiently delivers HCECs to restore corneal transparency without detectable toxicity or adverse effect on intraocular pressure. Magnetic delivery of HCECs may enhance corneal function and should be explored further for human therapies.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Xia X, Atkins M, Dalal R, et al. Magnetic Human Corneal Endothelial Cell Transplant: Delivery, Retention, and Short-Term Efficacy. Invest Ophthalmol Vis Sci. 2019. PMID: 31158276. doi:10.1167/iovs.18-26001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。